COMPANY DESCRIPTION
Employees: 1-10
Investment Type: Venture Capital
Portfolio 15
| Date | Name | Website | Total Raised | Location |
| - | Horizon Ph... | horizonpharma.com | $370K | United Sta... |
| - | Intact Vas... | intactvascular.com | $145.5M | United Sta... |
| - | Achillion ... | achillion.com | - | United Sta... |
| - | Melinta Th... | melinta.com | $137M | United Sta... |
| - | TELA Bio | telabio.com | $71.3M | United Sta... |
| - | TearScienc... | tearscience.com | $129.5M | United Sta... |
| - | NYDHA | digitalhealthaccelerator.com | - | - |
| - | Rapid Micr... | rapidmicrobio.com | $293.6M | United Sta... |
| - | Insmed | insmed.com | - | United Sta... |
| - | Vesper Med... | vespermedical.com | $37M | United Sta... |
Show more
Mentions in press and media 15
| Date | Title | Description |
| 12.02.2018 | Philly healthcare and life science investment firm 1315 Capital raises $300M+ for second fund | Among its portfolio companies are Geneoptix, an oncology molecular diagnostics business; Innovative Health seeks to reduce costs for reprocessing single-use medical devices; and orthopedic oncology business Onkos Surgical. Founding partner ... |
| 15.06.2016 | PE firm 1315 Capital raises $200M fund to invest in health tech, life sciences | What specific health technology trends spark your interest? We believe there is a significant opportunity in the smaller end of healthcare growth equity where Michael Koby and I have spent the vast majority of our investing careers. Massive... |
| 14.05.2015 | Intact Vascular Raises $38.9M in Series B VC Financing | Intact Vascular, Inc., a Wayne, Pa.-based developer of medical devices for minimally invasive peripheral vascular procedures, raised $38.9m in Series B venture capital financing. The round was led by New Enterprise Associates (NEA), with pa... |
| 15.04.2014 | Rapid Micro Biosystems Closes Additional Funding | Rapid Micro Biosystems, a Bedford, MA-based provider of automated, non-destructive, rapid microbial detection for quality control testing of pharmaceutical and personal care products, closed on additional funding of undisclosed amount. Back... |
| 29.06.2013 | Rapid Micro Biosystems Raises $32.6M in Series B Financing | Rapid Micro Biosystems, a Bedford, MA-based provider of microbial detection for quality control testing within the pharmaceutical and personal care products market segments, raised $32.6m in Series B financing. The round was led by Longitud... |
| 25.10.2012 | VC prediction: 2013 will be a good year for medtech deals | Adele Olivia of Quaker Partners was also optimistic and said the quality and opportunity of deals is unprecedented. “I just can’t believe the quality of teams we are seeing, and the state of assets,” she said. “This is a great time to be in... |
| 05.09.2012 | Intact Vascular Closes $15.5M Series A Financing | Intact Vascular, Inc., a Wayne, PA-based developer of medical devices for minimally invasive peripheral vascular procedures, has closed a $15.5m Series A financing. The round was co-led by Quaker Partners, H.I.G. BioVentures, with participa... |
| 29.06.2012 | Reaction to the Obamacare ruling: Investors | “The forces set in motion by the act are inevitable and must be systematically addressed in any event, i.e., healthcare must be made available to all people in the country, whether or not they are employed, whether or not they are poor, whe... |
| 16.03.2012 | Tarsa Therapeutics Closes $28M Series B Equity Financing | Tarsa Therapeutics, Inc., a Philadelphia, PA-based developer of a novel oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis, has closed a $28m Series B equity financing. The round was led by new in... |
| - | Medical device maker nets $4.7M to tackle peripheral artery disease complications | Medical device company Intact Vascular, which is developing tools to help the 8 million people with peripheral artery disease, has raised fresh capital. It has also started enrollment for a multi-center study to gather data supporting the s... |
Show more